Table 2.
Initial control | LAP +5 mmHg | LAP +10 mmHg | Final control | |
---|---|---|---|---|
Before hypertonic albumin infusion | ||||
RAR activity | 20.9 ± 9.5 | 18.8 ± 11.3 | 27.0 ± 11.2 | 17.2 ± 9.8 |
MLAP (mmHg) | 5.9 ± 1.5 | 10.8 ± 1.4 | 16.3 ± 1.4 | 5.8 ± 1.3 |
MABP (mmHg) | 72.8 ± 6.1 | 60.4 ± 5.3 | 53.4 ± 5.2† | 64.1 ± 3.4 |
HR (beats min−1) | 180.4 ± 13.9 | 182.2 ± 8.9 | 175.0 ± 5.1 | 164.0 ± 7.0 |
PITP (mmHg) | 4.8 ± 0.5 | 5.2 ± 0.6 | 5.8 ± 0.6 | 5.2 ± 0.5 |
After hypertonic albumin infusion | ||||
RAR activity‡ | 9.4 ± 3.2 | 30.6 ± 14.6 | 48.9 ± 10.1 | 18.4 ± 7.3 |
MLAP (mmHg) | 7.3 ± 2.0 | 11.8 ± 2.1 | 16.8 ± 1.8 | 4.6 ± 0.6 |
MABP (mmHg) | 79.4 ± 4.1 | 65.0 ± 5.0 | 63.2 ± 5.3† | 72.2 ± 4.1 |
HR (beats min−1) | 153.0 ± 11.1 | 155.4 ± 9.8 | 151.0 ± 12.5 | 154.8 ± 8.1 |
PITP (mmHg) | 4.5 ± 0.3 | 4.7 ± 0.3 | 5.2 ± 0.3 | 5.0 ± 0.5 |
Significantly lower than initial control period (P < 0.05, t test).
Significant change in activity when LAP is increased (P < 0.01, ANOVA and Dunnett's post hoc test).